Bachem Holding AG is a Switzerland-based biochemical company that provides services to the pharmaceutical and biotechnology industry. The Company focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The Company markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.

Pharmaceutical

Bachem

Thomas Meier

Torsten Wöhr

Ann-Kristin Jenssen

Guenther Loidl

Alain Schaffter

Viviane Minden

Anne-Kathrin Stoller

The Leadership Team at Bachem is responsible for setting strategic direction and overseeing the company's operations, financial health, and market positioning within the pharmaceutical and biotechnology industries. This diverse group of executives collaborates to drive innovation in peptide and organic molecule development, ensure compliance with industry standards, and foster business growth through effective marketing and global partnerships. Together, they aim to enhance Bachem's reputation as a leading supplier of active pharmaceutical ingredients and biochemical products.

Leadership Team

Supply Chain and Production Management

Quality Assurance and Regulatory Affairs

Leadership Team

About

Team members

Other teams at Bachem

Supply Chain and Production Management

Quality Assurance and Regulatory Affairs